期刊文献+

胰岛细胞移植术后远期疗效维持的研究进展

原文传递
导出
摘要 自1974年,明尼苏达大学Sutherland等实施了世界上首例人胰岛细胞移植治疗1型糖尿病以来[1],到今天已经有将近40年的临床历史了.然而胰岛细胞移植术后的临床疗效仍然欠佳.有报道显示[2],尽管临床上已经改良实施了Edmonton方案,在胰岛细胞移植术1 000 d后也仅有12%的受者仍能维持胰岛素非依赖状态.目前认为,影响临床胰岛细胞移植术后疗效的因素主要包括免疫排斥因素和非免疫排斥因素导致的胰岛损伤、丢失.本文将主要针对胰岛细胞移植术后非免疫排斥因素对其术后疗效的影响,以及胰岛细胞移植术后功能性胰岛细胞的监测方法综述如下.
出处 《国际外科学杂志》 2014年第6期376-379,共4页 International Journal of Surgery
基金 卫生部行业基金项目(No.201302009)
  • 相关文献

参考文献23

  • 1Sutherland DE,Gores PF,Farney AC,et al.Evolution of kidney,pancreas,and islet transplantation for patients with diabetes at the University of Minnesota[J].Am J Surg,1993,166 (5):456-491.
  • 2Witkowski P,Zakai SB,Rana A,et al.Pancreatic islet transplantation,what has been achieved since Edmonton break-through[J].Ann Transplant,2006,11 (2):5-13 ; discussion 32-43.
  • 3Eich T,Eriksson O,Lundgren T,et al.Visualization of early engraftment in clinical islet transplantation by positron-emission tomography[J].N Engl J Med,2007,356(26):2754-2755.
  • 4Eich T,Eriksson O,Sundin A,et al.Positron emission tomography:a real time tool to quantify early islet engraftment in a preclinical large animal model[J].Transplantation,2007,84 (7):893-898.
  • 5Moberg L,Korsgren O,Nilsson B.Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood[J].Clin Exp Immunol,2005,142(1):125-131.
  • 6Weir GC,Koulamnda M.Control of inflammation with Alphα1-antitrypsin:a potential treatment for islet transplantation and new-onset type 1 diabetes[J].Curr Diab Rep,2009,9(2):100-102.
  • 7Cui W,Angsana J,Wen J,et al.Liposomal formulations of thrombomodulin increase engraftment after intraportal islet transplantation[J].Cell Transplant,2010,19 (11):1359-1367.
  • 8Taoka Y,Okajima K,Uchiba M,et al.Neutoprotection by recombinant thrombomodulin[J].Thromb Haemost,2000,83 (3):462-468.
  • 9Kearon C,Comp P,Douketis J,et al.Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement[J].J Thromb Haemost,2005,3 (5):962-968.
  • 10Koh A,Senior P,Salam A,et al.Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success[J].Transplantation,2012,89 (4):465-741.

二级参考文献28

  • 1梁寒,唐贺文,郝希山,孙慧,李雯.活性炭吸附丝裂霉素C腹腔化疗的药代动力学研究[J].中华肿瘤杂志,2005,27(7):412-415. 被引量:29
  • 2陈志新,陈佳平,彭德恕,郑吉祥,谭建三.腹腔内热低渗液灌注化疗预防胃癌腹膜转移的实验研究和临床应用[J].中国肿瘤临床,1996,23(7):464-467. 被引量:19
  • 3Gao W,Demirici G,Strum TB,et al.Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces longterm islet allograft survival[J].Transplantation,2003,76(6):994-999.
  • 4Encapsulation & immunoprotective strategies of islet cells[J].Diabetes Technol Ther,2002,4(3):363-396.
  • 5Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 9. 7 million participants[J]. Lancet, 2011, 378(9785): 31-40.
  • 6Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes [ J ]. N Engl J Med, 2005, 352(25): 2598-2608.
  • 7Butler AE, Janson J, Bonnerweir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes [ J ]. Diabetes, 2003, 52(1) : 102-110.
  • 8Franco OH, Steyerberg EW, Hu FB, et al. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease [ J]. Arch Intern Med, 2007, 167 (11): 1145-1151.
  • 9Lakey JR, Mirbolooki M, Shapiro AM. Current status of clinical islet cell transplantation[J]. Methods Mol Biol, 2006, 333: 47-104.
  • 10Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors [J]. Cell, 2006, 126(4) : 663-676.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部